PN 200

Drug Profile

PN 200

Alternative Names: Naproxen/omeprazole; Omeprazole/naproxen

Latest Information Update: 25 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator POZEN
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Antipyretics; Antirheumatics; Antiulcers; Gastric antisecretories; Naphthaleneacetic acids; Non-opioid analgesics; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis

Most Recent Events

  • 25 Jan 2008 Discontinued - Phase-II for Ankylosing spondylitis in USA (PO)
  • 25 Jan 2008 Discontinued - Phase-II for Osteoarthritis in USA (PO)
  • 25 Jan 2008 Discontinued - Phase-II for Rheumatoid arthritis in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top